What is Gemini Therapeutics, Inc. (GMTX)?

Gemini Therapeutics, Inc. (GMTX) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

What is the current price of GMTX?

The current price of GMTX is $1.35. Prices are updated in real time on Stocks360.

What is GMTX's market capitalization?

GMTX's market capitalization is $25,491,780.00, placing it in the small-cap tier.

Gemini Therapeutics, Inc. (GMTX)

Stock analysis · NASDAQ · Healthcare · Biotechnology

$1.35

Market Cap

$25.49M

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

0.00

Day Range

$1.35 – $1.41

52-wk Range

$1.35 – $24.70

Avg Volume

N/A

Volume

60.42K

Gemini Therapeutics, Inc. (GMTX) is a publicly traded company in the Healthcare sector. Latest price: $1.35. Market cap $25.49M. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent

Aug 11, 2022

EPS $-1.60 vs est. $-2.00

Beat by $0.40

Proprietary Signals

Signal snapshot temporarily unavailable.

About Gemini Therapeutics, Inc.

Gemini Therapeutics, Inc. operates as a clinical-stage precision medicine enterprise, dedicated to crafting various therapeutic solutions for age-related macular degeneration (AMD) with a genetic foundation. Its flagship investigational product, GEM103, is a recombinant human complement factor H protein engineered to address dry AMD in patients. Beyond this, the firm is progressing GEM307, aimed at treating systemic ailments. Established in 2015, Gemini Therapeutics' operations are based out of Cambridge, Massachusetts.